デフォルト表紙
市場調査レポート
商品コード
1094390

自己免疫疾患診断の世界市場(疾患別、検査タイプ別、地域別)、COVID-19の影響、主要企業プロファイル、最近の発展-2028年までの予測

Autoimmune Disease Diagnostics Market (By Disease, Test Types, Region), Impact of COVID-19, Key Company Profiles, Recent Developments - Global Forecast to 2028

出版日: | 発行: iGate Research Pvt Ltd | ページ情報: 英文 145 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=136.25円
自己免疫疾患診断の世界市場(疾患別、検査タイプ別、地域別)、COVID-19の影響、主要企業プロファイル、最近の発展-2028年までの予測
出版日: 2022年06月21日
発行: iGate Research Pvt Ltd
ページ情報: 英文 145 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の自己免疫疾患診断の市場規模は、2021年に約140億米ドルとなりました。関節リウマチや橋本甲状腺炎などの疾患の有病率の上昇や、有利な政府規制の存在は、自己免疫疾患診断市場の成長に大きな影響を与えるとみられています。

当レポートでは、世界の自己免疫疾患診断市場について調査し、市場の概要とともに、疾患別、検査タイプ別、地域別の動向、COVID-19の影響、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 世界の自己免疫疾患診断市場に対するCOVID-19の影響

第3章 世界の自己免疫疾患診断市場と予測(2011年~2028年)

第4章 世界の自己免疫疾患診断市場のシェアと予測(2011年~2028年)

  • 疾患別-世界の自己免疫疾患診断の市場シェアと予測
  • 疾患別-世界の全身性自己免疫疾患診断の市場シェアと予測
  • 疾患別-世界の局所性自己免疫疾患診断の市場シェアと予測
  • 検査タイプ別-世界の自己免疫疾患診断の市場シェアと予測
  • 地域別-世界の自己免疫疾患診断の市場シェアと予測

第5章 疾患別-世界の自己免疫疾患診断市場と予測(2011年~2028年)

  • 世界の全身性自己免疫疾患診断
  • 世界の局所性自己免疫疾患診断

第6章 検査タイプ別-世界の自己免疫疾患診断市場と予測(2011年~2028年)

  • 自己抗体検査
  • 抗核抗体(ANA)検査
  • 全血球計算検査
  • 赤血球沈降速度試験
  • C-反応性タンパク質(CRP)検査
  • 尿検査
  • 包括的代謝パネルテスト
  • その他の検査

第7章 地域別-自己免疫疾患診断市場と予測(2011年~2028年)

  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第8章 自己免疫疾患診断市場-企業プロファイル

  • Abbott Laboratories
  • Siemens Healthineers
  • Roche Diagnostics
  • bioMerieux SA
  • EUROIMMUN AG
  • Bio-Rad Laboratories
  • Quest Diagnostics

第9章 世界の自己免疫疾患診断市場-最近の動向

第10章 世界の自己免疫疾患診断市場-促進要因

第11章 世界の自己免疫疾患診断市場-課題

図表

List of Figures

List of Figures:

  • Figure 3-1: Global - Autoimmune Disease Diagnostics Market (Million US$), 2011 - 2021
  • Figure 3-2: Global - Forecast for Autoimmune Disease Diagnostics Market (Million US$), 2022 - 2028
  • Figure 4-1: By Disease - Global Autoimmune Disease Diagnostics Market Share (Percent), 2011 - 2021
  • Figure 4-2: By Disease - Forecast for Global Autoimmune Disease Diagnostics Market Share (Percent), 2022 - 2028
  • Figure 5-1: Global - Systemic Autoimmune Disease Diagnostics Market (Million US$), 2011 - 2021
  • Figure 5-2: Global - Forecast for Systemic Autoimmune Disease Diagnostics Market (Million US$), 2022 - 2028
  • Figure 5-3: Global - Rheumatoid Arthritis Diagnostics Market (Million US$), 2011 - 2021
  • Figure 5-4: Global - Forecast for Rheumatoid Arthritis Diagnostics Market (Million US$), 2022 - 2028
  • Figure 5-5: Global - Ankylosing Spondylitis Diagnostics Market (Million US$), 2011 - 2021
  • Figure 5-6: Global - Forecast for Ankylosing Spondylitis Diagnostics Market (Million US$), 2022 - 2028
  • Figure 5-7: Global - Systemic Lupus Erythematosus Diagnostics Market (Million US$), 2011 - 2021
  • Figure 5-8: Global - Forecast for Systemic Lupus Erythematosus Diagnostics Market (Million US$), 2022 - 2028
  • Figure 5-9: Global - Others Systemic Autoimmune Disease Diagnostics Market (Million US$), 2011 - 2021
  • Figure 5-10: Global - Forecast for Others Systemic Autoimmune Disease Diagnostics Market (Million US$), 2022 - 2028
  • Figure 5-11: Global - Localized Autoimmune Disease Diagnostics Market (Million US$), 2011 - 2021
  • Figure 5-12: Global - Forecast for Localized Autoimmune Disease Diagnostics Market (Million US$), 2022 - 2028
  • Figure 5-13: Global - Inflammatory Bowel Disease Diagnostics Market (Million US$), 2011 - 2021
  • Figure 5-14: Global - Forecast for Inflammatory Bowel Disease Diagnostics Market (Million US$), 2022 - 2028
  • Figure 5-15: Global - Multiple Sclerosis Diagnostics Market (Million US$), 2011 - 2021
  • Figure 5-16: Global - Forecast for Multiple Sclerosis Diagnostics Market (Million US$), 2022 - 2028
  • Figure 5-17: Global - Type 1 Diabetes Diagnostics Market (Million US$), 2011 - 2021
  • Figure 5-18: Global - Forecast for Type 1 Diabetes Diagnostics Market (Million US$), 2022 - 2028
  • Figure 5-19: Global - Hashimoto's Thyroiditis Diagnostics Market (Million US$), 2011 - 2021
  • Figure 5-20: Global - Forecast for Hashimoto's Thyroiditis Diagnostics Market (Million US$), 2022 - 2028
  • Figure 5-21: Global - Others Localized Autoimmune Disease Diagnostics Market (Million US$), 2011 - 2021
  • Figure 5-22: Global - Forecast for Others Localized Autoimmune Disease Diagnostics Market (Million US$), 2022 - 2028
  • Figure 6-1: Global - Autoantibody Tests Market (Million US$), 2011 - 2021
  • Figure 6-2: Global - Forecast for Autoantibody Tests Market (Million US$), 2022 - 2028
  • Figure 6-3: Global - Antinuclear Antibody (ANA) Tests Market (Million US$), 2011 - 2021
  • Figure 6-4: Global - Forecast for Antinuclear Antibody (ANA) Tests Market (Million US$), 2022 - 2028
  • Figure 6-5: Global - Complete Blood Count Tests Market (Million US$), 2011 - 2021
  • Figure 6-6: Global - Forecast for Complete Blood Count Tests Market (Million US$), 2022 - 2028
  • Figure 6-7: Global - Erythrocyte Sedimentation Rate Tests Market (Million US$), 2011 - 2021
  • Figure 6-8: Global - Forecast for Erythrocyte Sedimentation Rate Tests Market (Million US$), 2022 - 2028
  • Figure 6-9: Global - C- Reactive Protein (CRP) Tests Market (Million US$), 2011 - 2021
  • Figure 6-10: Global - Forecast for C- Reactive Protein (CRP) Tests Market (Million US$), 2022 - 2028
  • Figure 6-11: Global - Urinalysis Tests Market (Million US$), 2011 - 2021
  • Figure 6-12: Global - Forecast for Urinalysis Tests Market (Million US$), 2022 - 2028
  • Figure 6-13: Global - Comprehensive Metabolic Panel Tests Market (Million US$), 2011 - 2021
  • Figure 6-14: Global - Forecast for Comprehensive Metabolic Panel Tests Market (Million US$), 2022 - 2028
  • Figure 6-15: Global - Other Tests Market (Million US$), 2011 - 2021
  • Figure 6-16: Global - Forecast for Other Tests Market (Million US$), 2022 - 2028
  • Figure 7-1: North America - Autoimmune Disease Diagnostics Market (Million US$), 2011 - 2021
  • Figure 7-2: North America - Forecast for Autoimmune Disease Diagnostics Market (Million US$), 2022 - 2028
  • Figure 7-3: Europe - Autoimmune Disease Diagnostics Market (Million US$), 2011 - 2021
  • Figure 7-4: Europe - Forecast for Autoimmune Disease Diagnostics Market (Million US$), 2022 - 2028
  • Figure 7-5: Asia Pacific - Autoimmune Disease Diagnostics Market (Million US$), 2011 - 2021
  • Figure 7-6: Asia Pacific - Forecast for Autoimmune Disease Diagnostics Market (Million US$), 2022 - 2028
  • Figure 7-7: Latin America - Autoimmune Disease Diagnostics Market (Million US$), 2011 - 2021
  • Figure 7-8: Latin America - Forecast for Autoimmune Disease Diagnostics Market (Million US$), 2022 - 2028
  • Figure 7-9: Middle East & Africa - Autoimmune Disease Diagnostics Market (Million US$), 2011 - 2021
  • Figure 7-10: Middle East & Africa - Forecast for Autoimmune Disease Diagnostics Market (Million US$), 2022 - 2028
  • Figure 8-1: Abbott Laboratories - Global Diagnostics Sales (Million US$), 2013 - 2021
  • Figure 8-2: Abbott Laboratories - Forecast for Global Diagnostics Sales (Million US$), 2022 - 2028
  • Figure 8-3: Siemens Healthineers - Global Diagnostics Sales (Million US$), 2013 - 2021
  • Figure 8-4: Siemens Healthineers - Forecast for Global Diagnostics Sales (Million US$), 2022 - 2028
  • Figure 8-5: Roche Diagnostics - Global Sales (Million US$), 2013 - 2021
  • Figure 8-6: Roche Diagnostics - Forecast for Global Sales (Million US$), 2022 - 2028
  • Figure 8-7: bioMerieux - Global Diagnostics Sales (Million US$), 2015 - 2021
  • Figure 8-8: bioMerieux - Forecast for Global Diagnostics Sales (Million US$), 2022 - 2028
  • Figure 8-9: EUROIMMUN AG - Estimated Global Sales (Million US$), 2014 - 2021
  • Figure 8-10: EUROIMMUN AG - Forecast for Global Sales (Million US$), 2022 - 2028
  • Figure 8-11: Bio-Rad Laboratories, Inc. - Global Diagnostics Sales (Million US$), 2014 - 2021
  • Figure 8-12: Bio-Rad Laboratories, Inc. - Forecast for Global Diagnostics Sales (Million US$), 2022 - 2028
  • Figure 8-13: Quest Diagnostics - Net Sales (Million US$), 2014 - 2021
  • Figure 8-14: Quest Diagnostics - Forecast for Net Sales (Million US$), 2022 - 2028

List of Tables:

  • Table 4-1: By Disease - Global Systemic Autoimmune Disease Diagnostics Market Share (Percent), 2011 - 2021
  • Table 4-2: By Disease - Forecast for Global Systemic Autoimmune Disease Diagnostics Market Share (Percent), 2022 - 2028
  • Table 4-3: By Disease - Global Localized Autoimmune Disease Diagnostics Market Share (Percent), 2011 - 2021
  • Table 4-4: By Disease - Forecast for Global Localized Autoimmune Disease Diagnostics Market Share (Percent), 2022 - 202830
  • Table 4-5: By Test Type - Global Autoimmune Disease Diagnostics Market Share (Percent), 2011 - 2021
  • Table 4-6: By Test Type - Forecast for Global Autoimmune Disease Diagnostics Market Share (Percent), 2022 - 2028
  • Table 4-7: By Region - Global Autoimmune Disease Diagnostics Market Share (Percent), 2011 - 2021
  • Table 4-8: By Region - Forecast for Global Autoimmune Disease Diagnostics Market Share (Percent), 2022 - 2028
目次

The global autoimmune disease diagnostics market was valued around US$ 14 Billion in 2021. Autoimmune diseases refer to a body's abnormal immune response leading to production of antibodies that attack own cells and tissues, causing deterioration and destruction of healthy tissues. There are almost 80 types of autoimmune diseases prevailing worldwide of which multiple sclerosis, type 1 diabetes, and rheumatoid arthritis are fairly common.

Autoimmune diseases can be divided into two general groups: Organ specific, where the autoantibodies attack a specific organ, and Non-organ specific (or systemic), where the autoantibodies attack multiple organ systems. As per the American Autoimmune Related Diseases Association, around 50 million Americans currently suffer from autoimmune related disorders. Moreover, the numbers are expected to escalate over the forecast period.

The tests used to diagnose the autoimmune disease include auto antibody test, antinuclear antibody test, complete blood count, C-reactive protein, and erythrocyte sedimentation rate. Rising prevalence of diseases such as rheumatoid arthritis, Hashimoto's thyroiditis, and presence of favorable government regulations will render significant impact on the autoimmune disease diagnostics market growth.

Impact of COVID-19 on Global Autoimmune Disease Diagnostics Market

The COVID-19 outbreak has become a global stress test. The COVID-19 disease has infected around 545 Million people worldwide. Globally the death toll has reached 6,342,015 according to the latest statistics from the Worldometers (as of June 21, 2022). The number is still growing, and the duration of the pandemic is still difficult to predict. The COVID-19 outbreak has created a sense of urgency and panic among people globally. However, many countries have taken strict measures to combat the coronavirus, such as mass vaccination program, social distancing, use of masks, etc. Manufacturers in the autoimmune disease diagnostics market are focusing on developing novel technologies for maximum testing within a minimum period. Thus, we expect that the physicians will see an increase in influx of patients, hence driving the autoimmune diseases diagnostics market growth.

By Disease - Global Autoimmune Disease Diagnostics Market and Forecast

  • On the basis of disease, Localized autoimmune disease segment accounted for largest market share in 2021.
  • Multiple sclerosis held highest share of the global localized autoimmune disease diagnostics market, followed by Inflammatory bowel disease segment.
  • Type 1 Diabetes captured third highest share of the global localized autoimmune disease diagnostics market in 2021.
  • Systemic autoimmune disease diagnostics segment will witness robust growth during the forecast timeframe.
  • Rheumatoid Arthritis captured over 50% share of the global systemic autoimmune disease diagnostics market in 2021, followed by Systemic lupus erythematosus (SLE).

By Tests Type - Global Autoimmune Disease Diagnostics Market and Forecast

  • On the basis of test types, Autoantibody Test captured highest share of the overall autoimmune disease diagnostics market.
  • The antinuclear antibodies (ANA) test captured second highest share of the global autoimmune disease diagnostics market.
  • The complete blood count (CBC) is one of the most commonly ordered blood tests.
  • Erythrocyte Sedimentation Rate Tests captured around 8% - 10% share of the global autoimmune disease diagnostics market followed by C -reactive protein test.
  • Urinalysis Tests and Comprehensive Metabolic Panel Tests are competing closely with each other to grab maximum share of the pie.

By Region - Autoimmune Disease Diagnostics Market and Forecast

  • North America dominates the global autoimmune disease diagnostics market and is expected to maintain its position throughout the forecast period.
  • Europe is the second largest region for autoimmune disease diagnostics market.
  • It is estimated that the prevalence rate of multiple sclerosis in Europe is 83 out of 100,000.
  • Asia-Pacific autoimmune disease diagnostics market is expected to grow at the fastest rate during the forecast period.
  • The Middle East & Africa and Latin America autoimmune disease diagnostics market is driven by the rising prevalence of autoimmune diseases and growing demand for better and accurate diagnostic procedures.

iGATE RESEARCH report titled "Autoimmune Disease Diagnostics Market (By Disease, Test Types, Region), Impact of COVID-19, Key Company Profiles, Recent Developments - Global Forecast to 2028" provides a comprehensive analysis of the Global Autoimmune Disease Diagnostic Market.

This 145 Page report with 66 Figures and 8 Tables has been analyzed from 9 View Points:

1) Global Autoimmune Disease Diagnostics Market and Forecast (2011 - 2028)

2) Impact of COVID-19 on Global Autoimmune Disease Diagnostics Market

3) Global Autoimmune Disease Diagnostics Market Share and Forecast (2011 - 2028)

4) By Disease - Global Autoimmune Disease Diagnostics Market and Forecast (2011 - 2028)

5) By Test Type - Global Autoimmune Disease Diagnostics Market and Forecast (2011 - 2028)

6) By Region - Autoimmune Disease Diagnostics Market and Forecast (2011 - 2028)

7) Autoimmune Disease Diagnostics Market - Company Profiles

8) Global Autoimmune Disease Diagnostics Market - Recent Developments

9) Global Autoimmune Disease Diagnostics Market - Growth Drivers & Challenges

By Disease - Global Autoimmune Disease Diagnostics Market and Forecast

Systemic Autoimmune Disease Diagnostics Market

  • Rheumatoid Arthritis
  • Ankylosing Spondylitis
  • Systemic Lupus Erythematosus
  • Others Systemic Autoimmune Disease

Localized Autoimmune Disease Diagnostics Market

  • Inflammatory Bowel Disease
  • Multiple Sclerosis
  • Type 1 Diabetes
  • Hashimoto's Thyroiditis
  • Others Localized Autoimmune Disease

By Test Type - Global Autoimmune Disease Diagnostics Market and Forecast

  • Autoantibody Tests
  • Antinuclear Antibody (ANA) Tests
  • Complete Blood Count Tests
  • Erythrocyte Sedimentation Rate Tests
  • C- Reactive Protein (CRP) Tests
  • Urinalysis Tests
  • Comprehensive Metabolic Panel Tests
  • Others Tests

By Region - Autoimmune Disease Diagnostics Market and Forecast

1. North America

2. Europe

3. Asia Pacific

4. Latin America

5. Middle East & Africa

Autoimmune Disease Diagnostics Market - Key Company Profiles, Strategy/Initiatives, Financial Insights

1. Abbott Laboratories

2. Siemens Healthineers

3. Roche Diagnostics

4. bioMerieux SA

5. EUROIMMUN AG

6. Bio-Rad Laboratories

7. Quest Diagnostics

Data Source

iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.

Research Methodologies

Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.

Table of Contents

1. Executive Summary

2. Impact of COVID-19 on Global Autoimmune Disease Diagnostics Market

3. Global Autoimmune Disease Diagnostics Market and Forecast (2011 - 2028)

4. Global Autoimmune Disease Diagnostics Market Share and Forecast (2011 - 2028)

  • 4.1 By Disease - Global Autoimmune Disease Diagnostics Market Share and Forecast
  • 4.2 By Disease - Global Systemic Autoimmune Disease Diagnostics Market Share and Forecast
  • 4.3 By Disease - Global Localized Autoimmune Disease Diagnostics Market Share and Forecast
  • 4.4 By Test Type - Global Autoimmune Disease Diagnostics Market Share and Forecast
  • 4.5 By Region - Global Autoimmune Disease Diagnostics Market Share and Forecast

5. By Disease - Global Autoimmune Disease Diagnostics Market and Forecast (2011 - 2028)

  • 5.1 Global Systemic Autoimmune Disease Diagnostics Market and Forecast
    • 5.1.1 Rheumatoid Arthritis Market and Forecast
    • 5.1.2 Ankylosing Spondylitis Market and Forecast
    • 5.1.3 Systemic Lupus Erythematosus Market and Forecast
    • 5.1.4 Others Systemic Autoimmune Disease Market and Forecast
  • 5.2 Global Localized Autoimmune Disease Diagnostics Market and Forecast
    • 5.2.1 Inflammatory Bowel Disease Market and Forecast
    • 5.2.2 Multiple Sclerosis Market and Forecast
    • 5.2.3 Type 1 Diabetes Market and Forecast
    • 5.2.4 Hashimoto's Thyroiditis Market and Forecast
    • 5.2.5 Others Localized Autoimmune Disease Diagnostics Market and Forecast

6. By Test Type - Global Autoimmune Disease Diagnostics Market and Forecast (2011 - 2028)

  • 6.1 Autoantibody Tests Market and Forecast
  • 6.2 Antinuclear Antibody (ANA) Tests Market and Forecast
  • 6.3 Complete Blood Count Tests Market and Forecast
  • 6.4 Erythrocyte Sedimentation Rate Tests Market and Forecast
  • 6.5 C- Reactive Protein (CRP) Tests Market and Forecast
  • 6.6 Urinalysis Tests Market and Forecast
  • 6.7 Comprehensive Metabolic Panel Tests Market and Forecast
  • 6.8 Other Test Market and Forecast

7. By Region - Autoimmune Disease Diagnostics Market and Forecast (2011 - 2028)

  • 7.1 North America - Autoimmune Disease Diagnostics Market and Forecast
  • 7.2 Europe - Autoimmune Disease Diagnostics Market and Forecast
  • 7.3 Asia Pacific - Autoimmune Disease Diagnostics Market and Forecast
  • 7.4 Latin America - Autoimmune Disease Diagnostics Market and Forecast
  • 7.5 Middle East & Africa - Autoimmune Disease Diagnostics Market and Forecast

8. Autoimmune Disease Diagnostics Market - Company Profiles

  • 8.1 Abbott Laboratories
    • 8.1.1 Company Overview
    • 8.1.2 Business Strategy
    • 8.1.3 Financial Insight
  • 8.2 Siemens Healthineers
    • 8.2.1 Company Overview
    • 8.2.2 Business Strategy
    • 8.2.3 Financial Insight
  • 8.3 Roche Diagnostics
    • 8.3.1 Company Overview
    • 8.3.2 Business Strategy
    • 8.3.3 Financial Insight
  • 8.4 bioMerieux SA
    • 8.4.1 Company Overview
    • 8.4.2 Business Strategy / Recent Developments
    • 8.4.3 Financial Insight
  • 8.5 EUROIMMUN AG
    • 8.5.1 Company Overview
    • 8.5.2 Recent Developments
    • 8.5.3 Financial Insight
  • 8.6 Bio-Rad Laboratories
    • 8.6.1 Company Overview
    • 8.6.2 Business Strategy / Recent Developments
    • 8.6.3 Financial Insight
  • 8.7 Quest Diagnostics
    • 8.7.1 Company Overview
    • 8.7.2 Business Strategy / Recent Developments
    • 8.7.3 Financial Insight

9. Global Autoimmune Disease Diagnostics Market - Recent Developments

10. Global Autoimmune Disease Diagnostics Market - Growth Drivers

  • 10.1 Rising Incidence of Autoimmune Diseases
  • 10.2 Growing Healthcare Expenditure to Promote the Growth of Market
  • 10.3 Growing Demand for Better and Accurate Diagnostic Procedures

11. Global Autoimmune Disease Diagnostics Market - Challenges

  • 11.1 Industry Challenges by Product Differentiation
  • 11.2 Shortcoming of Professional Operatives to Dampen the Growth of the Market